Previous 10 | Next 10 |
home / stock / viv:cc / viv:cc news
Avivagen Inc. (VIV:CA) is expected to report for Q1 2024
2023-08-30 20:00:00 ET Avivagen Inc is among the group of bottom performing stocks year-to-date on the TSX Venture Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year. This report is generated mon...
Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporti...
Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporti...
Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performan...
Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporti...
Avivagen Inc. (TSXV.VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporti...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, the...
Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health ...
News, Short Squeeze, Breakout and More Instantly...
Avivagen Inc. Company Name:
VIV:CC Stock Symbol:
TSXVC Market:
Yangaroo Inc. (YOO:CA) is expected to report for Q1 2024 Blue Horizon Global Capital Corp Com (BHCC:CNX) is expected to report for Q1 2024 GoldMoney Inc. (XAU:CA) is expected to report for Q4 2024 Avivagen Inc. (VIV:CA) is expected to report for Q2 2024 Imperial Ginseng Products L...
Mission Ready Solutions Inc. (MRS.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for Q3 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 ...
Green Impact Partners Inc. (GIP:CA) is expected to report for Q1 2024 AXMIN Inc. (AXM:CA) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 PUDO Inc (PDO:CNX) is expected to report for Q4 2024 Pedro Resources Ltd (VBN:CNX) is expected ...